von Wyl V - Search Results

1

Factors associated with material deprivation in persons with multiple sclerosis in Switzerland: Cross-sectional data from the Swiss Multiple Sclerosis Registry.

Sanak L, Kamm CP, Chan A, Stanikić M, Manjaly ZM, Zecca C, Calabrese P, von Wyl V; Swiss Multiple Sclerosis Registry (SMSR). Sanak L, et al. Among authors: von wyl v. Mult Scler Relat Disord. 2023 Jan;69:104438. doi: 10.1016/j.msard.2022.104438. Epub 2022 Dec 5. Mult Scler Relat Disord. 2023. PMID: 36495844 Free article.

2

Toward a Common Performance and Effectiveness Terminology for Digital Proximity Tracing Applications.

Lueks W, Benzler J, Bogdanov D, Kirchner G, Lucas R, Oliveira R, Preneel B, Salathé M, Troncoso C, von Wyl V. Lueks W, et al. Among authors: von wyl v. Front Digit Health. 2021 Aug 5;3:677929. doi: 10.3389/fdgth.2021.677929. eCollection 2021. Front Digit Health. 2021. PMID: 34713149 Free PMC article.

3

The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection.

Yerly S, Junier T, Gayet-Ageron A, Amari EB, von Wyl V, Günthard HF, Hirschel B, Zdobnov E, Kaiser L; Swiss HIV Cohort Study. Yerly S, et al. Among authors: von wyl v. AIDS. 2009 Jul 17;23(11):1415-23. doi: 10.1097/QAD.0b013e32832d40ad. AIDS. 2009. PMID: 19487906

4

Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoring.

von Wyl V, Cambiano V, Jordan MR, Bertagnolio S, Miners A, Pillay D, Lundgren J, Phillips AN. von Wyl V, et al. PLoS One. 2012;7(8):e42834. doi: 10.1371/journal.pone.0042834. Epub 2012 Aug 8. PLoS One. 2012. PMID: 22905175 Free PMC article.

5

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.

Gupta RK, Hill A, Sawyer AW, Cozzi-Lepri A, von Wyl V, Yerly S, Lima VD, Günthard HF, Gilks C, Pillay D. Gupta RK, et al. Among authors: von wyl v. Lancet Infect Dis. 2009 Jul;9(7):409-17. doi: 10.1016/S1473-3099(09)70136-7. Lancet Infect Dis. 2009. PMID: 19555900

6

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.

Yerly S, von Wyl V, Ledergerber B, Böni J, Schüpbach J, Bürgisser P, Klimkait T, Rickenbach M, Kaiser L, Günthard HF, Perrin L; Swiss HIV Cohort Study. Yerly S, et al. Among authors: von wyl v. AIDS. 2007 Oct 18;21(16):2223-9. doi: 10.1097/QAD.0b013e3282f0b685. AIDS. 2007. PMID: 18090050

7

African descent is associated with slower CD4 cell count decline in treatment-naive patients of the Swiss HIV Cohort Study.

Müller V, von Wyl V, Yerly S, Böni J, Klimkait T, Bürgisser P, Ledergerber B, Günthard HF, Bonhoeffer S; Swiss HIV Cohort Study. Müller V, et al. Among authors: von wyl v. AIDS. 2009 Jun 19;23(10):1269-76. doi: 10.1097/QAD.0b013e32832d4096. AIDS. 2009. PMID: 19461503

8

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study.

Pursuing Later Treatment Option II (PLATO II) project team; Observational HIV Epidemiological Research Europe (COHERE) Group; Costagliola D, Lodwick R, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, De Wit S, Obel N, Fätkenheuer G, Touoloumi G, Mussini C, Castagna A, Stephan C, García F, Zangerle R, Duval X, Pérez-Hoyos S, Meyer L, Ghosn J, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Phillips A. Pursuing Later Treatment Option II (PLATO II) project team, et al. Lancet Infect Dis. 2012 Feb;12(2):119-27. doi: 10.1016/S1473-3099(11)70248-1. Epub 2011 Oct 9. Lancet Infect Dis. 2012. PMID: 21988895 Free article.

9

Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection.

Huber M, Fischer M, Misselwitz B, Manrique A, Kuster H, Niederöst B, Weber R, von Wyl V, Günthard HF, Trkola A. Huber M, et al. Among authors: von wyl v. PLoS Med. 2006 Nov;3(11):e441. doi: 10.1371/journal.pmed.0030441. PLoS Med. 2006. PMID: 17121450 Free PMC article.

10

Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linked.

Huber M, von Wyl V, Ammann CG, Kuster H, Stiegler G, Katinger H, Weber R, Fischer M, Stoiber H, Günthard HF, Trkola A. Huber M, et al. Among authors: von wyl v. J Virol. 2008 Apr;82(8):3834-42. doi: 10.1128/JVI.02569-07. Epub 2008 Jan 30. J Virol. 2008. PMID: 18234794 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page